Epidemiological Investigation of Hepatitis C in Educational Institutes of Quetta City, Pakistan Research Article
Article Sidebar
Main Article Content
Abstract
Hepatitis C virus (HCV) infection remains a significant global public health issue, with approximately 157 million cases reported worldwide, including 71 million chronic infections, according to the World Health Organization. This study investigates the prevalence of HCV among students in various educational institutions in Quetta, Balochistan. A total of 400 serum samples were initially screened using immunochromatographic test (ICT) kits, and positive cases were further confirmed through quantitative PCR (qPCR). The study analyzed a range of demographic variables, including age, gender, educational level, and cultural background, and assessed risk factors such as prior surgical procedures and blood transfusions. Results showed that 7 out of 400 samples (1.75%) tested positive via ICT, while 5 (1.25%) were confirmed by qPCR. Most participants (75%) were aged 15–25 years, with a higher proportion of females (250/400; 63%) compared to males (150/400; 37%). These findings emphasize the need for targeted awareness campaigns in educational institutions to promote hygiene and reduce the risk of HCV transmission.
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Zelenev A, Li J, Shea P, Hecht R, Altice FL. Modeling combination hepatitis C virus treatment and prevention strategies in a network of people who inject drugs in the United States. Clinical Infectious Diseases. 2021;72(5):755-63.
2. Cozzani E, Herzum A, Burlando M, Parodi A. Cutaneous manifestations of HAV, HBV, HCV. Italian Journal of dermatology and venereology. 2019;156(1):5-12.
3. Audu RA, Okwuraiwe AP, Ige FA, Onyekwere CA, Lesi OA, Adeleye OO. Hepatitis C viral load and genotypes among Nigerian subjects with chronic infection and implication for patient management: a retrospective review of data. Pan African Medical Journal. 2020;37(1).
4. Ochei C, Obeagu EI, Ibegi BT, Ugobo EI, Odu M. Prevalence of hepatitis B and C from samples received from the various wards in Niger Delta University Teaching Hospital (NDUTH), Okolobiri for Hematological analyses. Merit Res. J. 2016;4(4):204-209.
5. Ekpenyong M, Tawari-ikeh P, Ekpenyong A. Investigation on the awareness of hepatitis B virus among health care workers in Nigeria. Nursing and Palliative Care. 2016;1(5):124-9.
6. Kashif M, Zaman F, Uzman MH, Shabbir T, Khan NU, Atta S, Shiraz S, Zahid MA, Munir A. Prevalence of Hepatitis C in Liver Cirrhosis Patients: HCV Prevalence in Cirrhosis Patients. Journal of Health and Rehabilitation Research. 2024;4(3):1-4.
7. Zulfiqar A, Iqbal T, Munir A. Machine Learning-Based Classification Algorithms for Predicting Hepatitis C: A Comprehensive Analysis. Journal of Computing & Biomedical Informatics. 2024;8(01).
8. Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C diagnosis: simplified solutions, predictive barriers, and future promises. Diagnostics. 2021;11(7):1253.
9. Henrietta P. Antiviral activity evaluation of pharmaceutical drugs, newly synthesized compounds and fragments against SARS-CoV-2 in vitro. Doctoral Thesis. University of Pécs, Biological and Sportbiological Doctoral School. 2023.
10. Elahimanesh Z, Bokharaei-Salim F, Donyavi T, Monavari SH, Tavakoli A, Khoshmirsafa M, Chavoshpour S, Abbasi-Kolli M, Ghalejoogh ZY, Kiani SJ. Prevalence of Hepatitis C Virus and Human Pegivirus Type 1 Co-Infection in Patients Infected with Human Immunodeficiency Virus Type-1. Prevalence. 2024;30(3):53-8.
11. Germer JJ, Harmsen WS, Mandrekar JN, Mitchell PS, Yao JD. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument. Journal of clinical microbiology. 2005;43(1):293-8.
12. Umutesi J, Liu CY, Penkunas MJ, Makuza JD, Ntihabose CK, Umuraza S, Niyikora J, Serumondo J, Gupta N, Nsanzimana S. Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population. BMJ open. 2019;9(7):e029743.
13. Usman A, Kuta FA, Saidu TB, Shittu OK. Seroprevalence and risk factors of hepatitis C virus infection among blood donors attending selected hospitals in Kaduna State. Microbes and Infectious Diseases. 202.
14. Puri P, Sharma PK, Nagpal AK. Viral hepatitis in India: armed forces perspective. medical journal armed forces india. 2016;72(3):201-3.
15. Alqahtani SA, Colombo M. Viral hepatitis as a risk factor for the development of hepatocellular carcinoma. Hepatoma Research. 2020;6:N-A.
16. Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at Bahir Dar Armed Forces General Hospital, Ethiopia. BMC Res Notes. 2015;8(1):1–6.
17. Negash M, Ayalew M, Geremew D, Workineh M. Seroprevalence and associated risk factors for HIV, Hepatitis B and C among blood Donors in South Gondar District blood Bank, Northwest Ethiopia. BMC infectious diseases. 2019;19:1-0
18. Moossavi M, Bahrami A, Rasekh H, Naghizadeh MS, Abd H, Fereidouni M. The prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections among a large population of Afghans. Hepatitis Monthly. 2020;20(7).
19. Umumararungu E, Ntaganda F, Kagira J, Maina N. Prevalence of hepatitis C virus infection and its risk factors among patients attending Rwanda Military Hospital, Rwanda. BioMed research international. 2017;2017(1):5841272.
20. Centers for Disease Control and Prevention (CDC). (2012). Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. MMWR. Morbidity and Mortality Weekly Report. 2012;61(RR 3):1-2.
21. Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ open gastroenterology. 2016;3(1):e000067.
22. Akhtar H, Badshah Y, Akhtar S, Hassan F, Faisal M, Qadri I. Prevalence of hepatitis B and hepatitis C Virus infections among male to female (MFT) transgenders in Rawalpindi (Pakistan). Advancements in Life Sciences. 2018;5(2):46-55.
23. Ahmad I. Prevalence of hepatitis B and C viral infection among pregnant women in Peshawar, Pakistan. Hepatitis monthly. 2016;16(6):e36383.
24. Tanveer Z, Ahmad I, Javed MS, Malik SA, Kakar NH, Ahmad M, Patching SG, Naeem M, Mustafa MZ. Screening for hepatitis b and c viral infections among pregnant women attending the Bolan Medical Complex Hospital and Sandeman Provincial Civil Hospital Quetta, Pakistan. The Professional Medical Journal. 2020;27(07):1328-34.
25. Babiker A, Hassan M, Muhammed S, Taylor G, Poonia B, Shah A, Bagchi S. Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review. Clinical cardiology. 2020;43(3):222-34.
26. Ahmed S, Baloch MA. Analysing the Socio-economic Factors Causing Hepatitis B and C in Baluchistan A Case Study of Quetta District. Pakistan Study Centre. 2017;5(1):235-50.
27. Saleem U, Aslam N, Siddique R, Iqbal S, Manan M. Hepatitis C virus: Its prevalence, risk factors and genotype distribution in Pakistan. European Journal of Inflammation. 2022;20:1721727X221144391.
28. Khan B, Iqbal A, Baloch MC, Ismail M, Nasir S, Iqbal B, Naseem M. Screening of Risk Factors and Subclinical Aspects for Hepatitis A, B and C in the Hospitalized Drug Addictives in “Treatment And Rehabilitation Center” in District Kech, Baluchistan. Pak-Euro Journal of Medical and Life Sciences. 2023;6(2):77-84.
29. Cui F, Faini D, Razavi-Shearer D, Razavi H, Manzengo Mingiedi C, Alonso Gonzalez M, Alaama AS, Mozalevskis A, Chan P, Izumi K, Ghrabi MA. Global Hepatitis Burden–Data for Action on Access of a Leading Infectious Disease Burden. 2025.
30. Memon GR, Siyal AR, Pathan MI, Shah IU. Comparison of Immunochromatography test (ICT) with real time polymerase chain reaction (RT–PCR) in detection of HCV. JMMC. 2016;7(2):21-3.